SSRP1 and nasopharyngeal carcinoma: Docetaxel treatment after SSRP1, Ets-1, or Pim-3 knockdown on apoptosis, inhibition of incursion, and clonogenicity in HNE-1 cells were not effective as NPC cell proliferation, apoptosis, autophagy, incursion, and clonogenicity have all been linked to SSRP1/Ets-1/Pim-3 signaling in the past.